The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell.
The post NICE recommends elranatamab for adults with a rare form of blood cancer appeared first on Cancer Research UK - Cancer News.
